| A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C) (NCT06964165) | Tesaro, Inc. | 2022-04-14 |
| Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer (NCT05061550) | AstraZeneca | 2022-04-14 |
| A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors (NCT05070247) | Takeda | 2022-04-14 |
| Feasibility of Cannabidiol for the Treatment of Long COVID (NCT04997395) | Bod Australia | 2022-04-14 |
| Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease (NCT06012500) | Children's Hospital Medical Center, Cincinnati | 2022-04-14 |
| A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (NCT05265286) | Hangzhou Gensciences Biopharmaceutical Co., Ltd. | 2022-04-14 |
| A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma (NCT05358379) | Cyclacel Pharmaceuticals, Inc. | 2022-04-14 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants (NCT05278663) | Eisai Co., Ltd. | 2022-04-14 |
| Epidiolex in Obsessive Compulsive Disorder and Related Disorders (NCT04978428) | University of Chicago | 2022-04-14 |
| Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder (NCT04982029) | Brigham and Women's Hospital | 2022-04-14 |
| Modified CV Regimen in Optic Pathway Glioma (NCT05278715) | Beijing Sanbo Brain Hospital | 2022-04-13 |
| A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible (NCT05280275) | Hellenic Society of Hematology | 2022-04-13 |
| A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome (NCT05098509) | Radius Pharmaceuticals, Inc. | 2022-04-13 |
| Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) (NCT05237284) | Sanofi | 2022-04-13 |
| A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia . (NCT05629598) | Angde Biotech Pharmaceutical Co., Ltd. | 2022-04-13 |
| Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine (NCT05313035) | PT Bio Farma | 2022-04-13 |
| A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC (NCT05291689) | Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) | 2022-04-13 |
| A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies (NCT05048082) | OncoNano Medicine, Inc. | 2022-04-13 |
| Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer (NCT04965714) | M.D. Anderson Cancer Center | 2022-04-13 |
| A Study of Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and Older (NCT05327816) | Janssen Vaccines & Prevention B.V. | 2022-04-13 |
| From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients (NCT06295328) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2022-04-13 |
| To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers (NCT05356741) | Vir Biotechnology, Inc. | 2022-04-13 |
| To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors (NCT05253053) | TransThera Sciences (Nanjing), Inc. | 2022-04-13 |
| Social Anxiety MDMA-Assisted Therapy Investigation (NCT05138068) | Jason B Luoma | 2022-04-13 |
| Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection (NCT05304715) | Hellenic Institute for the Study of Sepsis | 2022-04-13 |
| The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma (NCT05042128) | Australasian Gastro-Intestinal Trials Group | 2022-04-13 |
| Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone? (NCT05243563) | University of South Alabama | 2022-04-13 |
| The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis (NCT04976023) | Prof. Lin Zhixiu | 2022-04-12 |
| Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB (NCT05221502) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-04-12 |
| Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients (NCT05074810) | Verastem, Inc. | 2022-04-12 |
| Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor (NCT05216250) | AbbVie | 2022-04-12 |
| Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients (NCT05352347) | Shaperon | 2022-04-12 |
| Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer (NCT05016869) | Chinese Academy of Medical Sciences | 2022-04-12 |
| Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma (NCT05359861) | Coherus Oncology, Inc. | 2022-04-12 |
| IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study (NCT05417269) | Imcyse SA | 2022-04-12 |
| Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients (NCT05351021) | Mansoura University | 2022-04-12 |
| An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC (NCT05327582) | Chinese PLA General Hospital | 2022-04-12 |
| Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL (NCT05390749) | Peking Union Medical College Hospital | 2022-04-11 |
| A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease (NCT05104463) | CuraSen Therapeutics, Inc. | 2022-04-11 |
| 64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA) (NCT05249127) | Clarity Pharmaceuticals Ltd | 2022-04-11 |
| Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma (NCT04945720) | Sun Yat-sen University | 2022-04-11 |
| Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial (NCT05172934) | ProMedica Health System | 2022-04-11 |
| Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy (NCT05204160) | Emory University | 2022-04-11 |
| Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer (NCT05316155) | Janssen Research & Development, LLC | 2022-04-11 |
| Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women (NCT05367973) | Daré Bioscience, Inc. | 2022-04-11 |
| Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE (NCT05030831) | Inozyme Pharma | 2022-04-11 |
| A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection (NCT05238844) | Antios Therapeutics, Inc | 2022-04-11 |
| IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC (NCT05077709) | IO Biotech | 2022-04-11 |
| A Study of PM1022 in Patients With Advanced Tumors (NCT05867771) | Biotheus Inc. | 2022-04-11 |
| Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer (NCT05191797) | University of Washington | 2022-04-11 |
| XmAb20717 in Advanced Biliary Tract Cancers (NCT05297903) | Abramson Cancer Center at Penn Medicine | 2022-04-11 |
| Beetroot Juice for Boosting Immunity During a Time of Stress. (NCT06434181) | Baylor University | 2022-04-11 |
| Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy (NCT05322187) | RenJi Hospital | 2022-04-10 |
| The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients (NCT06539663) | Farwaniya Hospital | 2022-04-10 |
| Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases (NCT05325528) | Zhejiang University | 2022-04-10 |
| Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis (NCT05160532) | Mayo Clinic | 2022-04-10 |
| Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors (NCT05139043) | City of Hope Medical Center | 2022-04-09 |
| Off-the-shelf NK Cells + SCT for Myeloid Malignancies (NCT05115630) | M.D. Anderson Cancer Center | 2022-04-08 |
| Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant (NCT05222438) | Barbara Ann Karmanos Cancer Institute | 2022-04-08 |
| A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors (NCT05268666) | Jubilant Therapeutics Inc. | 2022-04-08 |
| Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients (NCT06124404) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-04-08 |
| Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer (NCT05395962) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2022-04-08 |
| Pediatric Pain Optimization After Tonsillectomy (NCT05244226) | Duke University | 2022-04-08 |
| Study of F-652 in Subjects With Corona Virus Disease 2019 (COVID-19) Pneumonia (NCT05205668) | EVIVE Biotechnology | 2022-04-08 |
| Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer (NCT05329532) | Scancell Ltd | 2022-04-07 |
| Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer (NCT05319873) | Jonsson Comprehensive Cancer Center | 2022-04-07 |
| GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer (NCT05419362) | Genome & Company | 2022-04-07 |
| Brain Oxygenation-II (NCT05171881) | Valerie Chock, M.D., M.S. Epi | 2022-04-07 |
| A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic (NCT05144685) | Oui Therapeutics, Inc. | 2022-04-07 |
| KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy (NCT05427383) | Shanghai JMT-Bio Inc. | 2022-04-07 |
| HTX-011 in Spinal Surgery (NCT04911062) | Heron Therapeutics | 2022-04-07 |
| Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM) (NCT05216653) | Sir Run Run Shaw Hospital | 2022-04-07 |
| A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL (NCT05265975) | Antengene Corporation | 2022-04-07 |
| Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma (NCT04807777) | Columbia University | 2022-04-07 |
| Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients (NCT04049851) | Center for Research on Filariasis and Other Tropical Diseases, Cameroon | 2022-04-07 |
| Serine and Fenofibrate Study in Patients With MacTel Type 2 (NCT04907084) | The Lowy Medical Research Institute Limited | 2022-04-07 |
| PDC-1421 Treatment in Adult Patients With ADHD (NCT05202327) | BioLite, Inc. | 2022-04-07 |
| A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough (NCT05392192) | Aldeyra Therapeutics, Inc. | 2022-04-07 |
| Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. (NCT05288478) | University of Chile | 2022-04-06 |
| Hypofractionated vs Conventional Fractionated RT in Soft Tissue Sarcomas (NCT05109494) | University of Wisconsin, Madison | 2022-04-06 |
| Personalized Feedback After Alcohol Health Education for Members of Greek Life (GREEK Study) (NCT05107284) | Abby Braitman | 2022-04-06 |
| PT-112 in Subjects With Thymoma and Thymic Carcinoma (NCT05104736) | National Cancer Institute (NCI) | 2022-04-06 |
| Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant (NCT04899349) | Novartis Pharmaceuticals | 2022-04-06 |
| Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma (NCT05097209) | Wei Jiang | 2022-04-06 |
| A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults (NCT05333289) | ModernaTX, Inc. | 2022-04-06 |
| A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) (NCT05323656) | Calliditas Therapeutics Suisse SA | 2022-04-06 |
| Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124 (NCT05459688) | AstraZeneca | 2022-04-06 |
| Neurocognitive Effects of FMT in MDD Patients With and Without IBS (NCT05174273) | Valerie Taylor | 2022-04-06 |
| Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis (NCT05190523) | Gannex Pharma Co., Ltd. | 2022-04-06 |
| Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS (NCT04957485) | SIGA Technologies | 2022-04-05 |
| Efficacy of TCM Capsules Lian Hua Qing Wen Jiao Nang in Mild COVID-19 Patients (NCT05275933) | Singapore Chung Hwa Medical Institution | 2022-04-05 |
| Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) (NCT04627428) | Luxa Biotechnology, LLC | 2022-04-05 |
| Niraparib in Tumors Metastatic to the CNS (NCT04992013) | Massachusetts General Hospital | 2022-04-05 |
| AllerPops Reduce Nasal Symptoms in Adult Volunteers With Allergic Rhinitis (NCT05956691) | AllerPops Corp | 2022-04-05 |
| Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma (NCT05324384) | West China Hospital | 2022-04-05 |
| Effect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomized Clinical Trial. (NCT05748561) | Asociación para Evitar la Ceguera en México | 2022-04-05 |
| Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome (NCT05298085) | University Hospital, Toulouse | 2022-04-05 |
| Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) (NCT05248659) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-04-05 |
| A Clinical Trial of PRAX-114 in Participants With Essential Tremor (NCT05387642) | Praxis Precision Medicines | 2022-04-05 |
| Multi-Center Study of ManNAc for GNE Myopathy (NCT04231266) | Leadiant Biosciences, Inc. | 2022-04-05 |